The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Domenico Mavilio, Luca Castagna et al.|Haematologica|2018Cited by 68